- Home
- HALO vs MASI Comparison
HALO vs MASI Comparison
Compare HALO & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- MASI
- Stock Information
- Founded
- HALO 1998
- MASI 1989
- Country
- HALO United States
- MASI United States
- Employees
- HALO N/A
- MASI N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- MASI Medical/Dental Instruments
- Sector
- HALO Health Care
- MASI Health Care
- Exchange
- HALO Nasdaq
- MASI Nasdaq
- Market Cap
- HALO 7.4B
- MASI 8.2B
- IPO Year
- HALO N/A
- MASI 2007
- Fundamental
- Price
- HALO $53.75
- MASI $149.91
- Analyst Decision
- HALO Buy
- MASI Buy
- Analyst Count
- HALO 9
- MASI 6
- Target Price
- HALO $63.56
- MASI $187.00
- AVG Volume (30 Days)
- HALO 3.3M
- MASI 679.1K
- Earning Date
- HALO 05-06-2025
- MASI 05-06-2025
- Dividend Yield
- HALO N/A
- MASI N/A
- EPS Growth
- HALO 55.40
- MASI N/A
- EPS
- HALO 3.76
- MASI N/A
- Revenue
- HALO $1,084,306,000.00
- MASI $2,126,800,000.00
- Revenue This Year
- HALO $25.77
- MASI N/A
- Revenue Next Year
- HALO $18.01
- MASI $7.74
- P/E Ratio
- HALO $14.29
- MASI N/A
- Revenue Growth
- HALO 25.64
- MASI 16.68
- 52 Week Low
- HALO $42.01
- MASI $101.61
- 52 Week High
- HALO $70.51
- MASI $194.88
- Technical
- Relative Strength Index (RSI)
- HALO 42.85
- MASI 41.83
- Support Level
- HALO $52.43
- MASI $152.84
- Resistance Level
- HALO $54.26
- MASI $156.41
- Average True Range (ATR)
- HALO 3.37
- MASI 5.06
- MACD
- HALO -0.70
- MASI -0.73
- Stochastic Oscillator
- HALO 27.16
- MASI 31.63
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.